Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 21471109 | HLA-DPB1 (HLA-DPB1) | beryllium disease | NA | NA | NA | unclassified | |
| rationaleberyllium sensitization (bes) and chronic beryllium disease (cbd) are determined by at least one genetic factor, a glutamic acid at position 69 (e69) of the hla-dpb1 gene, and by exposure to beryllium. | |||||||
| 22972925 | HLA-DPB1 (HLA-DPB1) | beryllium disease | NA | NA | NA | unclassified | |
| chronic beryllium disease, hla-dpb1, and the dp peptide binding groove. | |||||||
| 22972925 | HLA-DPB1 (HLA-DPB1) | beryllium disease | NA | NA | NA | unclassified | |
| multiple epidemiologic studies demonstrate associations between chronic beryllium disease (cbd), beryllium sensitization (bes), and hla-dpb1 alleles with a glutamic acid residue at position 69 (e69). | |||||||
| 22997873 | HLA (HLA) | beryllium disease | NA | NA | NA | unclassified | |
| an important exception to this has been the finding that the hla-dpb11(e69) allele is closely associated with chronic beryllium disease and beryllium sensitivity. | |||||||
| 22997873 | HLA-DPB1 (HLA-DPB1) | beryllium disease | NA | NA | NA | positive | |
| although chronic beryllium disease is only caused by exposure to beryllium, inheritance of hla-dpb1(e69) carries an increased risk of between two- and 30-fold in beryllium exposed workers. | |||||||
| 25369028 | HLA (HLA) | beryllium disease | NA | NA | NA | unclassified | |
| chronic beryllium disease: revealing the role of beryllium ion and small peptides binding to hla-dp2. | |||||||
| 31743304 | HLA-DPB1 (HLA-DPB1) | beryllium disease | NA | NA | NA | only_studied | |
| to evaluate interaction of hla-dpb1 and drb1 polymorphisms with metrics of beryllium exposure, in the development of beryllium sensitization (bes) and chronic beryllium disease (cbd). | |||||||
| 31743304 | HLA-DRB1 (HLA-DRB1) | beryllium disease | NA | NA | NA | only_studied | |
| to evaluate interaction of hla-dpb1 and drb1 polymorphisms with metrics of beryllium exposure, in the development of beryllium sensitization (bes) and chronic beryllium disease (cbd). | |||||||
| 34535537 | HLA-DPB1 (HLA-DPB1) | beryllium disease | NA | NA | NA | unclassified | |
| shuman leukocyte antigen-dp beta 1 (hla-dpb1) with a glutamic acid at the 69th position of the ss chain (e69) genotype and inhalational beryllium exposure individually contribute to risk of chronic beryllium disease (cbd) and beryllium sensitisation (bes) in exposed individuals. | |||||||
| 8108338 | HLA-B*08 | epidemic parotitis | NA | NA | NA | unclassified | |
| screening for antibodies to epidemic parotitis virus carried out in 61 patients with newly detected iddm revealed low antibody titers in the majority (83.3%) | |||||||
Copyright 2024